Skip to main content
OpenTrials

Clinical trial condition

Hormone-Resistant Prostate Cancer

Explore clinical trials studying Hormone-Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

33 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Hormone-Resistant Prostate Cancer trial results

Completed

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

NCT01270880

Conditions
Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Medicine nd Denistry of New Jersey Piscataway, New Jersey, United States
  • University of Wisconsin Cancer Center Riverview Wisconsin Rapids, Wisconsin, United States
View Trial Details
Completed

Tivantinib in Treating Patients With Metastatic Prostate Cancer

NCT01519414

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Michael Reese Hospital Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00486642

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston, Ontario, Canada
  • London Regional Cancer Program London, Ontario, Canada
View Trial Details
Completed

Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

NCT00936975

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Washington Medical Center Seattle, Washington, United States
View Trial Details

Related conditions